Targeting Ebola Virus Replication through Pharmaceutical Intervention

Hansen, F. and Feldmann, H. (2021). Targeting Ebola Virus Replication through Pharmaceutical Intervention. (Abstract only.) Expert Opinion on Investigational Drugs. 30(3):201-226.
This article discusses pharmaceutical interventions which can be used to treat Ebola virus disease. In particular, it examines the FDA-approved monoclonal antibody Inmazeb and the possibility of combining this with other pharmaceuticals which disrupt viral replication.
Favorite:
You must Login to add a comment
  • This item doesn't have any comments

Enter your email address to receive important announcements and updates through the ASPR TRACIE Listserv.